Covid-19 has hugely affected the modes of interaction between physicians and pharma Sales Force.
As of February 2021, most pharma companies in India re-started their F2F visits even though most corporate hospitals have restricted access to salesforce
What is keeping most CEOs awake – How to respond to customer expectations and adjust the content and format accordingly.
How to track complexities of implementation of a new model into marketing & sales teams.
Many research reports have indicated that a hybrid (mixed model) that includes face to face and digital interactions are favoured by most respondent Physicians.
The other challenge is the need to change the outdated traditional digital model, which is overused and creates digital noise into an innovative interactive model.
Register Now: https://lnkd.in/gmJK8et
Digital Excellence Pharma Academy Certification ProgramAnup Soans
Now on YouTube: Gartner's Top Five Priorities for Pharma Business Leaders and @Hariram K's Key Learning Points on Leadership
25-minute discussion with Deep Bhandari on the Gartner Report and Leadership Imperatives by Hariram Krishnan on How the DEPA Certification Program Can Make Pharma Professionals Future Proof
https://lnkd.in/gHiT_WU via @YouTube
Pharma saleforce effectiveness & digital marketing Kvantum Inc
Digital attribution is primarily associated with paid digital media and associated online click behavior. It is assumed that digital is effective, and since it saves cost of delivery of information it would be an effective channel. Pharmaceutical companies has absolutely no insight into how the digital interaction with the physician and the patient drives the efficacy of their current sales levers. At Kvantum, we help Pharma companies in answering questions like:
Does digital affect the need to reallocate spend on detailing vs sampling
Which type of digital interaction has the most impact on physician behavior when prescribing a drug, and how much time does it take digital interaction to influence that behavior
Does this behavior change with time?
Should the pharmaceutical company invest more in sales reps who can interact with a physician over email or chat?
Should the field sales rep call or meet less often, should part of these meetings be conducted over a digital medium
….
Bottomline, the effect of digital on sales in an unknown
Catalogue of training programs specifically designed for the pharmaceutical industry. Programs covering: Strategy - Marketing - Sales force effectiveness - Market research - Management - Project Management. Proposition of seminars and masterclasses
The business and people behind a new service or program are critical for stakeholders to evaluate a business plan. This presents what is needed in the plan's business description and why.
Digital Excellence Pharma Academy Certification ProgramAnup Soans
Now on YouTube: Gartner's Top Five Priorities for Pharma Business Leaders and @Hariram K's Key Learning Points on Leadership
25-minute discussion with Deep Bhandari on the Gartner Report and Leadership Imperatives by Hariram Krishnan on How the DEPA Certification Program Can Make Pharma Professionals Future Proof
https://lnkd.in/gHiT_WU via @YouTube
Pharma saleforce effectiveness & digital marketing Kvantum Inc
Digital attribution is primarily associated with paid digital media and associated online click behavior. It is assumed that digital is effective, and since it saves cost of delivery of information it would be an effective channel. Pharmaceutical companies has absolutely no insight into how the digital interaction with the physician and the patient drives the efficacy of their current sales levers. At Kvantum, we help Pharma companies in answering questions like:
Does digital affect the need to reallocate spend on detailing vs sampling
Which type of digital interaction has the most impact on physician behavior when prescribing a drug, and how much time does it take digital interaction to influence that behavior
Does this behavior change with time?
Should the pharmaceutical company invest more in sales reps who can interact with a physician over email or chat?
Should the field sales rep call or meet less often, should part of these meetings be conducted over a digital medium
….
Bottomline, the effect of digital on sales in an unknown
Catalogue of training programs specifically designed for the pharmaceutical industry. Programs covering: Strategy - Marketing - Sales force effectiveness - Market research - Management - Project Management. Proposition of seminars and masterclasses
The business and people behind a new service or program are critical for stakeholders to evaluate a business plan. This presents what is needed in the plan's business description and why.
The new pharma, customer centric, databased business modelA.R.J. (Rob) Halkes
Customer focus is the core and the basis for all commercial activities for pharma. Customers, physicians and patients expect effective therapies in drugs and support. Sustainable relations with customers are necessary to build trusted relations to create a cooperation to realize that. This tells you how to!
BioClinitech- Services And Capabilitiesshravan1198
We are a Medico-Marketing Support Service and Customized IT Solutions Company established
in 2004 and offering innovative products and services to the global pharmaceutical and biotech
industries. Headquartered in Mumbai with a branch office in Hyderabad, the firm was conceived as an attempt to manage the information overload and provide customized and innovative solutions to the global healthcare and allied industries.
The team is a blend of global professionals with wide experience in Healthcare, IT, Biotechnology
and broad training in business and strategy
Our products and services provide clients with the innovative solutions to maximize growth
opportunities and life-cycle of existing products.
Business model includes a comprehensive suite of services designed to impart a global
perspective in two distinct portfolios: IT Solutions - Website Development & Maintenance and
Medico-Marketing Support Services
This presentation defines what is a Business Model and illustrates them using a Business Model Canvas. It identifies generic business models that are common in community pharmacies and provides examples.
Infographic: How to meet the new communication expectations?Kasper Roger Larsen
In partnership with Anthill agency we have produced this infographic with information on how to meet the new evolving expectations in digital communication for the life science industry.
Health Tech Strategy Extern job descriptionKeith Rabkin
Hey everyone, my team is looking to hire two externships out of consulting. If you're at any of the firms that offer an externship or know someone who is, this is a great chance to work with a team tackling some interesting challenges at the intersection of Tech and Healthcare. Please let me know if you have any questions.
DigiStorm 2018 brings together the best of Indian Pharma business leaders to share their insights & perspectives.
Pharmaceutical companies have been increasing their engagement with the digital world slowly and cautiously.
But the industry has now reached a tipping point: it has to put an end to hiding behind the challenges of engaging with its stakeholders digitally and stop treating digital as an add-on to existing operations. Rather, it needs to embrace a “digital first” engagement model with fundamental consequences for its organization and capabilities. - AT Kearney
New Medicine for a New World
Time for Pharma to Dive into Digital
Decades ago, Peter Drucker was invited to address the senior management team at General Motors, he asked them a simple, but penetrating question: “Why should I buy a GM car?”
Many senior executives attempted to answer that simple question but, nobody was able to give a convincing answer! The senior managers at General Motors had unlearnt the art of winning customers by not being able to answer the simple question - “Why should I buy a GM car?” But they kept introducing more and more new models which less and less customers bought. And that was the prelude to GM’s decline and bankruptcy.
That question still resonates for every business including Indian Pharma. I wonder how many field sales people - Medical Reps and their managers can answer the question - Why Should the Doctor Rx Your Product? Having a clear answer to that question is the key to winning customers - be they doctors, chemists, distributors or hospitals.
As companies grow larger, hierarchies are created and sales processes like CRM/SFA evolve and become embedded. In the absence of a dynamic top leadership, hierarchy and processes become rigid and difficult to change even though rapidly changing market dynamics demand that they do. Bureaucracy slows down customer-centric decision making and inaction becomes part of the organisation's culture. The emphasis shifts from developing employees and winning customers to launching products and hitting numbers.
Peter Drucker rarely blamed individuals; he saw root causes in the design of organizations—in their structures, processes, norms, and routines. He would ask leaders a few provocative questions: “What is your mission? What should you stop doing? Where has the drive for short-term efficiencies undermined long-term effectiveness? What should be your objectives and guiding principles?”
The new pharma, customer centric, databased business modelA.R.J. (Rob) Halkes
Customer focus is the core and the basis for all commercial activities for pharma. Customers, physicians and patients expect effective therapies in drugs and support. Sustainable relations with customers are necessary to build trusted relations to create a cooperation to realize that. This tells you how to!
BioClinitech- Services And Capabilitiesshravan1198
We are a Medico-Marketing Support Service and Customized IT Solutions Company established
in 2004 and offering innovative products and services to the global pharmaceutical and biotech
industries. Headquartered in Mumbai with a branch office in Hyderabad, the firm was conceived as an attempt to manage the information overload and provide customized and innovative solutions to the global healthcare and allied industries.
The team is a blend of global professionals with wide experience in Healthcare, IT, Biotechnology
and broad training in business and strategy
Our products and services provide clients with the innovative solutions to maximize growth
opportunities and life-cycle of existing products.
Business model includes a comprehensive suite of services designed to impart a global
perspective in two distinct portfolios: IT Solutions - Website Development & Maintenance and
Medico-Marketing Support Services
This presentation defines what is a Business Model and illustrates them using a Business Model Canvas. It identifies generic business models that are common in community pharmacies and provides examples.
Infographic: How to meet the new communication expectations?Kasper Roger Larsen
In partnership with Anthill agency we have produced this infographic with information on how to meet the new evolving expectations in digital communication for the life science industry.
Health Tech Strategy Extern job descriptionKeith Rabkin
Hey everyone, my team is looking to hire two externships out of consulting. If you're at any of the firms that offer an externship or know someone who is, this is a great chance to work with a team tackling some interesting challenges at the intersection of Tech and Healthcare. Please let me know if you have any questions.
DigiStorm 2018 brings together the best of Indian Pharma business leaders to share their insights & perspectives.
Pharmaceutical companies have been increasing their engagement with the digital world slowly and cautiously.
But the industry has now reached a tipping point: it has to put an end to hiding behind the challenges of engaging with its stakeholders digitally and stop treating digital as an add-on to existing operations. Rather, it needs to embrace a “digital first” engagement model with fundamental consequences for its organization and capabilities. - AT Kearney
New Medicine for a New World
Time for Pharma to Dive into Digital
Decades ago, Peter Drucker was invited to address the senior management team at General Motors, he asked them a simple, but penetrating question: “Why should I buy a GM car?”
Many senior executives attempted to answer that simple question but, nobody was able to give a convincing answer! The senior managers at General Motors had unlearnt the art of winning customers by not being able to answer the simple question - “Why should I buy a GM car?” But they kept introducing more and more new models which less and less customers bought. And that was the prelude to GM’s decline and bankruptcy.
That question still resonates for every business including Indian Pharma. I wonder how many field sales people - Medical Reps and their managers can answer the question - Why Should the Doctor Rx Your Product? Having a clear answer to that question is the key to winning customers - be they doctors, chemists, distributors or hospitals.
As companies grow larger, hierarchies are created and sales processes like CRM/SFA evolve and become embedded. In the absence of a dynamic top leadership, hierarchy and processes become rigid and difficult to change even though rapidly changing market dynamics demand that they do. Bureaucracy slows down customer-centric decision making and inaction becomes part of the organisation's culture. The emphasis shifts from developing employees and winning customers to launching products and hitting numbers.
Peter Drucker rarely blamed individuals; he saw root causes in the design of organizations—in their structures, processes, norms, and routines. He would ask leaders a few provocative questions: “What is your mission? What should you stop doing? Where has the drive for short-term efficiencies undermined long-term effectiveness? What should be your objectives and guiding principles?”
Digital Service Providers to Indian Pharma - An Interactive OpportunityAnup Soans
Want to test/partner your digital eHealth initiative with Indian Pharma. We have a special interactive session at #DigiStorm2018 for digital service providers with pharma decision-makers.
Prabir Jha, President & GCHRO at Cipla and other Eminent Indian Pharma Thought Leaders discuss Digital Transformation as the Future of Successful Pharma Business
To laud some of these companies that have consistently remained on the top, we featured them in our latest edition of Insights Success, Companies in Focus.
How pcd pharma franchises are changing the indian pharmaceutical industry?Fossil Remedies
In the past few years India has seen a tremendous growth in every sector the pharmaceutical sector is also not an exception. Here you know how PCD Pharma Franchises are changing the Indian pharmaceutical Industry.
‘Pharmaceuticals in India’ is a never ending discussion over its growth potential, opportunities, strengths and how your organization can capitalize on them. At the same time, it is essential to know what obstacles you will face while doing so. To dissect this exciting opportunity, here's India’s first ever conference on commercial excellence in pharma
India Beauty and Personal Care Market PPT(2022- 2027) : Trends, Scope, Demand...IMARC Group
According to the latest report by IMARC Group, the India beauty and personal care market is anticipated to grow at a CAGR of 6.5% during 2022-2027.Beauty and personal care products are generally utilized for improving the appearance and overall health of skin, nails and hair. They are widely used for beautifying and cleaning purposes that aid in enhancing the physical appearance of individuals.
The 10 Most Influential Leaders in Medtech- 2023.pdfInsightsSuccess4
This edition features a handful of The 10 Most Influential Leaders in Medtech leaders across several sectors that are at the forefront of leading us into a digital future
CE- 2012 is a one day action packed conference focusing on implementing effective commercial strategies that are necessary to increase revenues and profitability in the complex Indian landscape of today.
Pharma Marketing - Improvement or Insanity? August MedicinManAnup Soans
1. Pharma Marketing: Continuous Improvement or Insanity? by Salil Kallianpur
Why does Indian pharma insist on fixing a model that seems to be obsolete?
2. The Marks of a Super Rep by Shashikant Iyengar
Small things that make a BIG difference in the life of a Medical Rep.
3. Customer-Centric Interaction for the Medical Rep by Srinivas Pothapragada
The sales process that puts the Customer at the center of your sales interactions.
4. Prepare to Promote by K. Hariram
How to build a pipeline of capable individuals to fill the roles of FLM and SLM.
5. Why Great Strategy Often Fails by Prof. Vivek Hattangadi
How to avoid the pitfalls of strategy execution.
6. Introduction to Diabetes Mellitus by Dr. Amit Dang
What the Field Force needs to know about the disease that affects over 50 million Indians.
7. Five Steps to Breakthrough Performance by Anup Soans
How FLMs can deliver breakthrough sales performance with their teams.
Kodak didn’t go out of business because people stopped taking pictures. They just failed to read and acknowledge the emerging Digital Era...
.....................................................................................
Digital in Indian Pharma - Case Studies and Discussions. Be there at BrandStorm 2016 on 17th Feb - The Courtyard Marriott Mumbai.
Similar to MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th (20)
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...Anup Soans
Key Point from the Q &A with Dr. Mandar Kubal, Mumbai
Telemedicine has become a very useful tool for clinicians to manage their patients.
Given the ever changing contours of Covid19 treatment, doctors have to check daily for online resources.
It would be wonderful if pharma can provide every specialty the latest developments in treating Covid19 with pre existing conditions instead of sending their unvaccinated field force to give brand reminders.
Pharma should seek frontline worker status for Medical Reps and Field Managers as they are critical to maintain the drug supply chain.
Treat the Field Force as an asset and protect them, instead of pushing them onto the field without vaccination.
And many more insights from a clinician at the frontlines of treating Covid19 patients.
Now on MedicinMan YouTube Channel - https://youtu.be/J_p3paeO_eg
Key Challenges Facing Pharma Industry and the Way ForwardAnup Soans
Suresh Subramanian, pharma veteran discusses Key Challenges Facing Pharma Industry and the Way Forward on Saturday, 27th March at 6 PM on https://www.credoweb.in/discussion/630/key-challenges-facing-pharma-industry-and-the-way-forward
Key Account Management - Time for India Pharma to Adopt KAMAnup Soans
Pharma's 40-year Model of Pitching to the HCPs is Over says Hanno Wolfram author of Key Account Management in Pharma...
Watch the webinar on Digital Excellence Pharma Academy today at 6 PM to know more - https://lnkd.in/gjZRN6q
How can Pharma Use Digital to Engage Doctors and Understand PatientsAnup Soans
Doctors and patients are already using digital for many healthcare needs. Telemedicine is a prime example.
A Webinar by Dr. Shenoy Robinson today at 6 PM on - https://www.credoweb.in/discussion/604/how-can-pharma-use-digital-to-engage-doctors-and-understand-patients
How can Pharma Use Digital to Engage Doctors and Understand Patients
Why Indian Pharma Needs to Enable Managers to Develop TalentAnup Soans
People need the support of their leaders and organisations processes to develop their talents.
Deep Bhandari delves deep into the topic of Talent Development and its impact on individuals and organisations.
Architecture To Develop Pharma Business Leaders For Today and Tomorrow Anup Soans
4 Factors of Digital Transformation
1. Leadership Mindset for Digital Transformation
2. Digital Transformation - Why and How to Do it Right
3. Sales and Sales Management - Challenges & Solutions
4. Customer/Patient Centricity - Why and How to Do it Right
What is Indian Pharma Thinking about Digital? A Research ProjectAnup Soans
First Ever Indian Pharma Centric Survey: A CredoWeb India – #MedicinMan Research Project
As a part of Digital Excellence Pharma Academy , we initiated a research project with a detailed survey to understand the current status and issues faced by Indian Pharma companies in adopting digital to bridge the pharma – physicians disconnect.
You can know more about the scope and scale of this research project and survey at https://lnkd.in/gR5JMer
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramAnup Soans
Ready for the next Webinar on Digitalisation of Pharma Marketing?
Digital Excellence Pharma Academy a partnership between MedicinMan and CredoWeb not only equips pharma/devices/diagnostics/disposable company employees with KA$H (you’ll learn about KA$H soon in the future webinars), but offers you the ability to adopt the digital platform to communicate and engage your customers and create lasting experiences to build your relationship with customers.
To know more on how to engage doctors via digital, attend 40+ webinars brought to you by CredoWeb in partnership with MedicinMan - follow 3 simple steps:
Go to www.credoweb.in
Create your “Pharma professional” registration
Follow Digital Excellence Pharma Academy page and stay tuned for our webinars for which you will be cordially invited
The Mankind Pharma Story by Dr. Sumit GhoshalAnup Soans
Mankind was established in 1991, almost a decade after the industry leaders of today including Dr.Reddy’s and Sun Pharma, but has grown considerably faster than its contemporaries...
One reason for this is that unlike major drug makers who have a large portfolio of hundreds of products, mankind prefers to concentrate on a much smaller number of high value products. “they don’t bother with smaller products with a potential value of less than Rs.5 crore,” says a long-time industry watcher. thus Health OK, their OTC product, which is a combination of vitamins and nutritional medicines was able to generate Rs.50 crore in revenue within a year of its launch in 2014-15.
This is also the approach adopted by some multinationals like Sanofi, whose CEO Chris Viebacher said, that his company obtained a lion’s share of its revenue from just 15 top selling patented products...
Indian Pharma and Retail Pharmacies - Sales View PollAnup Soans
The Sales View poll concluded with valuable information on several key aspects of the Indian Pharmaceutical field force, especially in the strategies employed by medical sales reps to obtain marketing intelligence. With sales force considered to be a strong pillar of the pharmaceutical industry, gaining pointers on their day-to-day operations, and challenges faced, is indeed an asset in improving the pharma industry.
Such weekly and monthly data analysis by IQVIA and leading pharma KOLs will help you understand market dynamics better. Do participate in our polls and keep up with the latest opinions and trends on IQVIA Sales View.
Healthcare's Future will be Patient ExperienceAnup Soans
With healthcare reform now opening the door to more insured patients, it is not overwhelming what we hear nowadays that market access is dead and patient access is the new prescription for healthcare marketing.
Patient access helps when there is precariousness in the benefits, which will never be fully known until a product is used in the real world and over a period of time.
A patient access centered mindset aims to understand the patient and provider pathways, with the ultimate objective that all those patients who can optimally benefit from a product can have the access to the product.
Instead of a win/lose mindset at the core of market access, patient access tries to create win/win/win solutions that lead to value for patients, companies, and the healthcare system at large.
In such a scenario, several issues that should deal with patient access should be addressed such as:
Patient access as a guiding principle across all functions
Developing a clear and compelling value proposition for each stakeholder group
Creating a formal framework for understanding the impact of decisions on patient access
Getting payer input and advice early on
Enhanced patient satisfaction
Improved communication through shared data
Unethical Practices in Pharma - Interesting Study from Pakistan Anup Soans
This study clarifies the current pharmaceutical drug promotion and prescribing practices in Pakistan. The majority of prescribers and national pharmaceutical firms and to some extent the multinational pharmaceuticals are involved in unethical practices in drug promotion and prescribing. Alarming policies governing the drug promotion and prescribing are required to be implemented by the concerned regulatory authorities to avoid unnecessary harm to the patient’s life and pocket through the unethical drug promotion. The prescribers should not accept any incentives, gifts of financial value from any pharmaceutical companies in return for an increase in prescribing selected brand. On the other hand, pharmaceutical companies must compete in the market on the basis of the drug quality and do not offer any valuable gift and incentives to the prescribers. The interaction between doctors and phar- maceutical firms should be restricted within acceptable boundaries and the authorities must be prepared to play an active role. Strengthening the regulatory machinery and formulating policies in this regard in neces- sary. It is essential that a health care professional such as a pharmacist can play an important role in this process since he/she is an expert in the pharmaceutical field as well as more aware of the outcomes of unethical drug prescribing practices such as polypharmacy and adverse drug reactions.
Healthcare in India - a Dystopian World | Book review by Dr. Sumit GhosalAnup Soans
Once upon a time, there used to be something known as the medical profession, comprising of doctors, nurses and others who worked at hospitals. in those good old days, over 90 per cent of hospitals and health centres were publicly owned – central or state government, municipal corporations, companies and so on. there were also a few charitable trust hospitals that functioned in a similar manner as the public hospitals.
Things began to change in the 1980s, when the first ‘for-profit’ hospital (apollo) was set up, and the central government redefined hospitals as the “healthcare industry” making them eligible for bank loans and other forms of financing. and medical professionals became known as “healthcare providers” though some senior doctors didn’t quite like the new designation.
The book, Healers or Predators, is not just timely, but also very appropriate. in his foreword, Nobel Laureate, Amartya Sen describes the scenario as depressing, but the situation is much more – a dystopian world from which there is no escape! the reason is a combination of exploitative hospitals, a callous government, nearly non-existent regulation of all parties – doctors, hospitals, medical gadget manufacturers, and the pharma sector!
The book covers a wide canvas: from the flaws in the Medical Council of India, to moral, ethical and societal questions affecting the medical profession.
The Amazonisation of Healthcare - Start with the Customer & Work BackwardsAnup Soans
Whether Amazon succeeds in the healthcare market, or not, remains to be seen but the reason I believe healthcare is about to get ‘Amazonized’ is because of what Chris Holt, Amazon’s leader of Global Healthcare said recently:
“When we think about the healthcare space, our overall philosophy of obsessing around the customer has served us really well. So, we start with the customer and we work backwards.”
Such thinking comes as breath of fresh air – so antithetic it is to the current thinking in healthcare. Incumbents might smirk at it, but customer obsession is the primary reason why Amazon and other tech companies have built giant corporations at an unbelievable pace.
The rules of the digital economy are different from what we are normally used to. That is why a shift in thinking and mindset is key to winning. New ways of doing business come with new rules...
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
2. P V Sankar Dass
CEO & Director
Curatio Healthcare (I) Pvt Ltd
Curatio is Dermatology focused company with 200 Cr turnover and
800 people.
Completing the fourth decade in Pharma this year , Sankar started his
career as a MR in Cipla.
Grew to become Vice President-Strategy in Dr.Reddy’s playing
leadership roles in different business verticals of DRL, where he was
recognized for building all the mega brands.
In his tenure of 25 years at DRL he has also worked in different
countries outside India. He is also known for grooming talents in Sales
& Marketing functions.
Register on: https://lnkd.in/gmJK8et
3. Dr. T S PARMAR
MD & CEO, Albert David Ltd.
Over 33 years of experience in the Indian Pharma / Healthcare
Industry with leading MNCs and Indian pharma companies
Wide exposure across the width of functional roles including
Marketing, Sales, Strategy, M&As, General Management etc.
Regular Speaker / Panel Member in leading conferences in India &
Abroad including CPHI, Rotary / Lions, AMA, State CII, Doctor
Associations etc.
Albert David has a turnover of Rs.313 Crores and ranks amongst the
Top 100 pharma companies of India
Register on: https://lnkd.in/gmJK8et
4. Covid-19 has hugely affected the modes of interaction between physicians and pharma Sales Force.
As of February 2021, most pharma companies in India re-started their F2F visits even though most
corporate hospitals have restricted access to sales force
What is keeping most CEOs awake – How to respond to customer expectations and adjust the content and
format accordingly.
How to track complexities of implementation of a new model into marketing & sales teams.
Many research reports have indicated that a hybrid (mixed model) that includes face to face and digital
interactions are favoured by most respondent Physicians.
The other challenge is the need to change the outdated traditional digital model, which is overused and
creates digital noise into an innovative interactive model.
Register on: https://lnkd.in/gmJK8et
5. How have pharma marketing and medical teams
adopted and accepted the new realties?
Key Questions that CEOs will Discuss
Register on: https://lnkd.in/gmJK8et
6. What way are pharma redesigning services
to meet the HCP behavior changes?
Key Questions that CEOs will Discuss
Register on: https://lnkd.in/gmJK8et
7. What are the major challenges in digital adoption?
Overview of the MedicinMan – CredoWeb Survey on Digital Adoption in Indian Pharma
Key Questions that CEOs will Discuss
Register on: https://lnkd.in/gmJK8et
8. 6 Major Challenges in Digital Adoption
1
2
3
4
5
6
Availability of right talent
(internal) (43%)
Sales force resistance
(43%)
Poorly defined benefits
and key outcomes (43%)
Poor communication and
change management process
(46%)
Change in the leadership
priorities (33%)
Availability of right talent
(external) (23%)
MedicinMan Survey
9. What can pharma companies do to
overcome these challenges?
Overview of the MedicinMan – CredoWeb Survey on Digital Adoption in Indian Pharma
Register on: https://lnkd.in/gmJK8et
10. What Pharma can do to build
digitally skilled teams?
Overview of the MedicinMan – CredoWeb Survey on Digital Adoption in Indian Pharma
Key Questions that CEOs will Discuss
Register on: https://lnkd.in/gmJK8et